rs879255585
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PP2PP3_ModeratePP5_Very_Strong
The NM_001830.4(CLCN4):c.823G>A(p.Val275Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 22)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
CLCN4
NM_001830.4 missense
NM_001830.4 missense
Scores
15
1
1
Clinical Significance
Conservation
PhyloP100: 9.55
Genes affected
CLCN4 (HGNC:2022): (chloride voltage-gated channel 4) The CLCN family of voltage-dependent chloride channel genes comprises nine members (CLCN1-7, Ka and Kb) which demonstrate quite diverse functional characteristics while sharing significant sequence homology. Chloride channel 4 has an evolutionary conserved CpG island and is conserved in both mouse and hamster. This gene is mapped in close proximity to APXL (Apical protein Xenopus laevis-like) and OA1 (Ocular albinism type I), which are both located on the human X chromosome at band p22.3. The physiological role of chloride channel 4 remains unknown but may contribute to the pathogenesis of neuronal disorders. Alternate splicing results in two transcript variants that encode different proteins. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 13 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CLCN4. . Gene score misZ 4.5166 (greater than the threshold 3.09). GenCC has associacion of gene with non-syndromic X-linked intellectual disability, intellectual disability, X-linked 49.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.874
PP5
Variant X-10206756-G-A is Pathogenic according to our data. Variant chrX-10206756-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 209117.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-10206756-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCN4 | NM_001830.4 | c.823G>A | p.Val275Met | missense_variant | 8/13 | ENST00000380833.9 | NP_001821.2 | |
CLCN4 | NM_001256944.2 | c.541G>A | p.Val181Met | missense_variant | 6/11 | NP_001243873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCN4 | ENST00000380833.9 | c.823G>A | p.Val275Met | missense_variant | 8/13 | 1 | NM_001830.4 | ENSP00000370213.4 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1089958Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 356392
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1089958
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
356392
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 18, 2022 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27550844, 33880059) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 10, 2023 | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 275 of the CLCN4 protein (p.Val275Met). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 275 of the CLCN4 protein (p.Val275Met). This variant is not present in population databases (gnomAD no frequency). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with CLCN4-related conditions (PMID: 27550844, 33880059, 36385166). In at least one individual the variant was observed to be de novo. This missense change has been observed in individual(s) with CLCN4-related conditions (PMID: 27550844, 33880059, 36385166). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 209117). ClinVar contains an entry for this variant (Variation ID: 209117). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCN4 protein function with a positive predictive value of 95%. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCN4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. For these reasons, this variant has been classified as Pathogenic. - |
CLCN4-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Sydney Children's Hospital, SCHN | Mar 22, 2016 | De novo variant. Clinical phenotype consistent with case series of individuals with CLCN4 related disorder. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Pathogenic
.;D;D
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
.;M;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D
Sift4G
Pathogenic
D;D;D
Polyphen
1.0
.;D;.
Vest4
MutPred
0.64
.;Loss of catalytic residue at V275 (P = 0.003);Loss of catalytic residue at V275 (P = 0.003);
MVP
MPC
2.4
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at